These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34329710)

  • 1. Cyclodextrin based bone regenerative inclusion complex for resveratrol in postmenopausal osteoporosis.
    Shah AA; Shah A; Lewis S; Ghate V; Saklani R; Narayana Kalkura S; Baby C; Singh PK; Nayak Y; Chourasia MK
    Eur J Pharm Biopharm; 2021 Oct; 167():127-139. PubMed ID: 34329710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation.
    Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S
    Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, optimization of the inclusion complex of glaucocalyxin A with sulfobutylether-β-cyclodextrin and antitumor study.
    Ren L; Wang J; Chen G
    Drug Deliv; 2019 Dec; 26(1):309-317. PubMed ID: 30896265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation, characteristic and pharmacological study on inclusion complex of sulfobutylether-β-cyclodextrin with glaucocalyxin A.
    Ren L; Jing J; Chen G; Miao Y; Wei P
    J Pharm Pharmacol; 2014 Jul; 66(7):927-34. PubMed ID: 24697809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of sulfobutyl-ether-β-cyclodextrin levels in oral formulations to enhance progesterone bioavailability.
    Shankar VK; Police A; Pandey P; Cuny ZG; Repka MA; Doerksen RJ; Murthy SN
    Int J Pharm; 2021 Mar; 596():120212. PubMed ID: 33493605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of morin/hydroxypropyl-β-cyclodextrin inclusion complex: Enhancement of bioavailability, antihyperalgesic and anti-inflammatory effects.
    Lima BDS; Campos CA; da Silva Santos ACR; Santos VCN; Trindade GDGG; Shanmugam S; Pereira EWM; Marreto RN; Duarte MC; Almeida JRGDS; Quintans JSS; Quintans LJ; Araújo AAS
    Food Chem Toxicol; 2019 Apr; 126():15-24. PubMed ID: 30738132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chloramphenicol/sulfobutyl ether-β-cyclodextrin complexes in an ophthalmic delivery system: prolonged residence time and enhanced bioavailability in the conjunctival sac.
    Xu Y; Zhang C; Zhu X; Wang X; Wang H; Hu G; Fu Q; He Z
    Expert Opin Drug Deliv; 2019 Jun; 16(6):657-666. PubMed ID: 31033370
    [No Abstract]   [Full Text] [Related]  

  • 8. Sulfobutyl ether(7) β-cyclodextrin (SBE(7) β-CD) carbamazepine complex: preparation, characterization, molecular modeling, and evaluation of in vivo anti-epileptic activity.
    Jain AS; Date AA; Pissurlenkar RR; Coutinho EC; Nagarsenker MS
    AAPS PharmSciTech; 2011 Dec; 12(4):1163-75. PubMed ID: 21918921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation of Curcumin-β-cyclodextrin-polyvinylpyrrolidone supramolecular inclusion complex: experimental, molecular docking, and preclinical anti-inflammatory assessment.
    Jafar M; Khalid MS; Aldossari MFE; Amir M; Alshaer FI; Adrees FAA; Gilani SJ; Alshehri S; Hassan MZ; Imam SS
    Drug Dev Ind Pharm; 2020 Sep; 46(9):1524-1534. PubMed ID: 32808552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfo-butyl ether β-cyclodextrin inclusion complexes of bosutinib: in silico, in vitro and in vivo evaluation in attenuating the fast-fed variability.
    Shah S; Famta P; Vambhurkar G; Bagasariya D; Kumar KC; Srinivasarao DA; Begum N; Sharma A; Shahrukh S; Jain N; Khatri DK; Srivastava S
    Drug Deliv Transl Res; 2024 May; 14(5):1218-1231. PubMed ID: 37903963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The formation of a host-guest inclusion complex system between β-cyclodextrin and baicalin and its dissolution characteristics.
    Li J; Jiang Q; Deng P; Chen Q; Yu M; Shang J; Li W
    J Pharm Pharmacol; 2017 Jun; 69(6):663-674. PubMed ID: 28299800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of sodium sulfobutylether-β-cyclodextrin based on encapsulation.
    Huang J; Wang X; Huang T; Yang Y; Tu J; Zou J; Yang H; Yang R
    Carbohydr Polym; 2024 Jun; 333():121985. PubMed ID: 38494236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion Complex of Docetaxel with Sulfobutyl Ether β-Cyclodextrin: Preparation, In Vitro Cytotoxicity and In Vivo Safety.
    Ren L; Yang X; Guo W; Wang J; Chen G
    Polymers (Basel); 2020 Oct; 12(10):. PubMed ID: 33066097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and Characterization of the Sulfobutylether-β-Cyclodextrin Inclusion Complex of Amiodarone Hydrochloride with Enhanced Oral Bioavailability in Fasted State.
    Wang D; Chen G; Ren L
    AAPS PharmSciTech; 2017 Jul; 18(5):1526-1535. PubMed ID: 27757923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and in vivo evaluation of an inclusion complex of oridonin and 2-hydroxypropyl-beta-cyclodextrin.
    Yan Z; Xu W; Sun J; Liu X; Zhao Y; Sun Y; Zhang T; He Z
    Drug Dev Ind Pharm; 2008 Jun; 34(6):632-41. PubMed ID: 18568914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing Bedaquiline for Effective Non-Small Cell Lung Cancer (NSCLC) Therapy as Inhalable Cyclodextrin-Based Molecular Inclusion Complexes.
    Parvathaneni V; Elbatanony RS; Goyal M; Chavan T; Vega N; Kolluru S; Muth A; Gupta V; Kunda NK
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental, molecular docking investigations and bioavailability study on the inclusion complexes of finasteride and cyclodextrins.
    Mady FM; Farghaly Aly U
    Drug Des Devel Ther; 2017; 11():1681-1692. PubMed ID: 28652706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclodextrins: Efficient biocompatible solubilizing excipients for bromhexine liquid and semi-solid drug delivery systems.
    Stojanov M; Nielsen HM; Larsen KL
    Int J Pharm; 2012 Jan; 422(1-2):349-55. PubMed ID: 22027391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Thymoquinone-Sulfobutylether-β-Cyclodextrin Inclusion Complex for Anticancer Applications.
    Eid EEM; Almaiman AA; Alshehade SA; Alsalemi W; Kamran S; Suliman FO; Alshawsh MA
    Molecules; 2023 May; 28(10):. PubMed ID: 37241838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhalable resveratrol-cyclodextrin complex loaded biodegradable nanoparticles for enhanced efficacy against non-small cell lung cancer.
    Wang X; Parvathaneni V; Shukla SK; Kulkarni NS; Muth A; Kunda NK; Gupta V
    Int J Biol Macromol; 2020 Dec; 164():638-650. PubMed ID: 32693132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.